Drugs / Donor T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00356928 | Oct 2006 → May 2011 | leukemia, myelodysplastic syndrome | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Donor T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00356928 ↗ |
| Modality | Cell therapy | “infusion of allogeneic T-cell depleted donor lymphocytes” NCT00356928 ↗ |
| Route | Intravenous | “CD8-depleted T cells given IV on Day 0.” NCT00356928 ↗ |